Menstrual health comprises the physical, social and mental aspects related to menstruation or periods. In India, women's health has been given secondary importance due to a male dominant society, illiteracy, low socio-economic conditions and ignorance.
The most common causes of menstrual problems are PCOS (Polycystic Ovarian Syndrome), and abnormal or heavy menstrual bleeding. Menstruation or monthly periods have been associated with a lot of social and cultural taboos in India.
Many young girls and women do not have facilities to manage their menses hygienically, maintaining their privacy, dignity and gender equality at home, schools and workplaces.
So, what are normal periods? A normal menstrual period lasts from 2-7 days and comes at an interval of 21-35 days. It is difficult to quantify the actual menstrual flow. In general, use of three to four XL or regular size sanitary pads per day (since they need to be changed every six to eight hours) can be considered normal on an average, but it may vary depending on the individual.
Common Menstrual Problems
1. Menstrual hygiene
2. Menstrual flow
3. Menstrual cycle
4. Menstrual hormones
Menstrual Hygiene Related Problems: Use of unclean sanitary pads or clothes can give rise to genital tract infections, anaemia and urinary tract Infection. This can be prevented by social awareness and easy availability of affordable sanitary products. It is also important to have the right knowledge about menstrual hygiene to avoid such issues from taking place.
Menstrual Flow Related Problems: One can experience excess or scanty flow during periods. Usually heavy menstrual flow can be for 1-2 days but if it continues for more than 5-7 days, it can lead to low haemoglobin and anaemia. This definitely needs to be investigated and treated along with oral iron replacement therapy. The less flow or change in flow over years can be due to hormonal imbalance. This can occur mostly after completion of family in perimenopausal age.
Menstrual Cycle Related Problems: Irregular periods, skipping or not getting periods for more than six months (also known as secondary amenorrhoea) and bleeding in between periods (called inter menstrual bleeding) are a few problems under this type of problem. The most common cause for this is Polycystic Ovarian Syndrome (PCOS), stress, anxiety and depression. Investigations in the form of pelvic sonography and hormonal investigations are necessary to make a diagnosis. Regular exercise, a balanced diet and healthy lifestyle changes are important.
Menstrual Hormone Related Problems: This usually gives rise to psychomotor issues. They can be symptoms of Premenstrual Syndrome (PMS) at any age group or peri/postmenopausal vasomotor symptoms after the age of 45. Bloating, breast tenderness, irritability and depression which occur premenstrually and disappear with onset of periods are classical symptoms of PMS. If they are affecting day to day family life, then it needs to be treated.
Every woman experiences menopausal symptoms in varying severity, starting usually 4-5 years before menopause. The night sweats, hot flushes, low moods, anxiety, irritability, joint and muscle pain, loss of interest in having sex, and weight gain are typical menopausal symptoms due to deficiency of oestorgen hormones.
No matter which type of menstrual problem you're facing, it is always advisable to visit a gynaecologist who will be able to identify all your queries after making the right diagnosis.
Nua, a new-age brand transforming the women's wellness space in India with holistic and personalised solutions that addresses real problems faced by women in managing their menstrual health and personal hygiene, provides an innovative range of products and services, including India's first customizable pack of sanitary pads and self-heating menstrual cramp patches, also available on a subscription basis. (Vaishali Joshi, #NuaExpert on Gynaecology, is an Obstetrician and Gynaecologist at Kokilaben Dhirubhai Ambani Hospital, Mumbai)
Read More► Post Diwali, Delhi hospital sees 10% more respiratory problem patients
New York - Women who contract Covid-19 during pregnancy are at significantly higher risk of developing pre-eclampsia, the leading cause of maternal and infant death worldwide, according to a new study.
Pre-eclampsia is a sudden increase in blood pressure after the 20th week of pregnancy.
The study, published in the American Journal of Obstetrics and Gynecology, showed that women with SARS-CoV-2 infection during pregnancy had 62 per cent higher odds of developing preeclampsia than those without the infection during pregnancy.
"This association was remarkably consistent across all predefined subgroups. Moreover, SARS-CoV-2 infection during pregnancy was associated with a significant increase in the odds of pre-eclampsia with severe features, eclampsia and HELLP syndrome," said Roberto Romero, Professor of Molecular Obstetrics and Genetics at the Wayne State University School of Medicine.
HELLP syndrome is a form of severe pre-eclampsia that includes hemolysis (the rupturing of red blood cells), elevated liver enzymes and a low platelet count.
The team published their findings after reviewing 28 previous studies that included 790,954 pregnant women, including 15,524 diagnosed with Covid-19 infection.
"Both asymptomatic and symptomatic infection significantly increased the risk of pre-eclampsia," Romero said.
"Nevertheless, the odds of developing pre-eclampsia were higher among patients with symptomatic illness than among those with asymptomatic illness."
Pre-eclampsia warning signs, in addition to elevated blood pressure, can include headaches, swelling in the face and hands, blurred vision, chest pain and shortness of breath.
The condition is responsible for 76,000 maternal deaths and more than 500,000 infant deaths every year, according to estimates from the Pre-eclampsia Foundation.
The babies of pre-eclamptic mothers are affected by the condition and may develop intrauterine growth restriction or die in utero.
The researchers said health care professionals should be aware of the association and closely monitor pregnant women who are infected for early detection of pre-eclampsia.
A separate study, published in the American Journal of Obstetrics and Gynecology-Maternal-Fetal Medicine, showed that women who receive the mRNA Covid-19 vaccine during pregnancy pass high levels of antibodies to their babies.
The study of 36 newborns whose mothers received either the Pfizer-BioNTech or Moderna Covid-19 vaccine during pregnancy showed that 100 per cent of the infants had protective antibodies at birth.
Read More► Viral fever rages in Bihar among kids
लखनऊ | 'डेंटल स्लीप मेडिसिन' पर एक सम्मेलन के अनुसार भारत में करीब 40 लाख लोग, खासकर बुजुर्ग और मोटे लोग ऑब्सट्रक्टिव स्लीप एपनिया (ओएसए) सिंड्रोम से पीड़ित हैं। सोमवार को यहां आयोजित सम्मेलन में विशेषज्ञों ने कहा कि अगर कोई व्यक्ति सांस लेने में तकलीफ के कारण रात में कई बार जागता है और पूरे दिन सिरदर्द और थकान के साथ सुबह शुष्क मुंह का अनुभव करता है, तो यह ओएसए के कारण हो सकता है।
श्वसन चिकित्सा में, ओएसए का आमतौर पर निरंतर पॉजिटिव वायुमार्ग दबाव मशीनों के साथ इलाज किया जाता है, लेकिन दंत चिकित्सा भी आसान प्रबंधन प्रदान करती है।
सरस्वती डेंटल कॉलेज के डीन और सम्मेलन के आयोजक प्रोफेसर अरविंद त्रिपाठी ने कहा, "मोटापा, जीवन शैली का तनाव और दांतों का पूरा गिरना ऊपरी वायुमार्ग में संपीड़न का कारण बन सकता है। यह सांस लेने पर प्रतिकूल प्रभाव डालता है। अगर ऐसी स्थिति लंबे समय तक बनी रहती है और अनुपचारित छोड़ दी जाती है, तो यह शरीर की ऑक्सीजन की आवश्यकता को प्रभावित करती है और हृदय और श्वसन संबंधी समस्याएं पैदा कर सकती है।"
दंत चिकित्सा में, विशेषज्ञों ने कहा, इस स्थिति का इलाज मैंडिबुलर उन्नति उपकरण के साथ किया जा सकता है, एक मौखिक उपकरण जो अस्थायी रूप से जबड़े और जीभ को आगे बढ़ाता है, गले के कसने को कम करता है और वायुमार्ग की जगह को बढ़ाता है।
विश्व स्वास्थ्य संगठन के लखनऊ कार्यालय के डॉ अंकुर ने कहा, "लगभग 80 प्रतिशत रोगियों को नहीं पता कि वे ओएसए से पीड़ित हैं और यह घातक हो सकता है, इसलिए लोगों को इसके बारे में बुनियादी जानकारी होनी चाहिए।"
यह भी पढ़े► कैंसर और हार्ट अटैक से ज्यादा खतरनाक हो जाएगा सेप्सिस: शोध
London, Aug 17 (IANS) Patients with Long Covid syndrome continue to have higher measures of blood clotting, which may help explain their persistent symptoms, such as reduced physical fitness and fatigue, finds a research.
While the dangerous clotting has been observed in patients with severe acute Covid-19, far less is known about Long Covid syndrome, where symptoms can last weeks to months after the initial infection has resolved and is estimated to affect millions of people worldwide.
Researchers from RCSI University of Medicine and Health Sciences in Ireland, examined 50 patients with symptoms of Long Covid syndrome to better understand if abnormal blood clotting is involved.
They discovered that clotting markers were significantly elevated in the blood of patients with Long Covid syndrome compared with healthy controls. These clotting markers were higher in patients who required hospitalisation with their initial Covid-19 infection, but they also found that even those who were able to manage their illness at home still had persistently high clotting markers.
In the study, published in the Journal of Thrombosis and Haemostasis, the team observed that higher clotting was directly related to other symptoms of Long Covid syndrome, such as reduced physical fitness and fatigue. Even though markers of inflammation had all returned to normal levels, this increased clotting potential was still present in the Long Covid patients.
"Because clotting markers were elevated while inflammation markers had returned to normal, our results suggest that the clotting system may be involved in the root cause of Long Covid syndrome," said lead author Dr Helen Fogarty, doctoral student at the Irish Centre for Vascular Biology in the RCSI School of Pharmacy and Biomolecular Sciences.
In a separate study, a team from the University of Cambridge, in the UK, found that small protein molecules called cytokines could have a link to the Long Covid condition, the Daily Mail reported.
Cytokines, which are produced by the body in response to infections, are often found to be lingering in a person's body for months after infection.
They developed a simple new blood test that may determine whether or not Covid-19 survivors will experience long-term symptoms.
Brussels, Aug 5 (IANS) The European Commission announced it has approved a deal that allows European Union (EU) member states to buy up to 200 million doses of Novavax's Covid-19 jab, once the European Medicines Agency (EMA) deems it safe and effective for use.In a statement on Weednesday, the Commission said that through the agreement with the US pharmaceutical firm, EU countries will be able to purchase 100 million Novavax vaccine doses, with the option to purchase a further 100 million over the course of 2021, 2022, and 2023, reports Xinhua news agency.European Commission President Ursula von der Leyen hailed the deal as further strengthening the bloc's "broad vaccine portfolio".The EU has already signed contracts with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNTech-Pfizer, CureVac, Moderna and concluded exploratory talks with Valneva. The previously concluded contracts secured a portfolio of up to 4.4 billion doses.Rich western nations have been accused of hoarding far more doses than their citizens need. The Washington Post previously estimated that the US has bought coronavirus vaccines three times the amount needed, while many developing countries are still struggling to get a single dose.The World Health Organization (WHO) on Wednesday called on rich countries to halt the plan to distribute Covid-19 booster shots, citing vaccine inequity around the world."We need an urgent reversal from the majority of vaccines going to high-income countries, to the majority going to low-income countries," WHO Director General Tedros Adhanom Ghebreyesus told a press briefing.--IANSksk/
New Delhi, July 19 (IANS) Doctors at the Max Hospitals in Saket and Vaishali have successfully treated a critically ill, underweight, pre-term baby suffering from a condition known as PDA or Patent Ductus Arteriosus using a device called Piccolo.Nishu, born pre-maturely in Western UP, developed respiratory problems after birth. He was also diagnosed with PDA -- a common condition detected in new-borns.PDA causes a duct or an opening in a child's heart to stay open which otherwise would have closed within 3-7 days of the birth. This causes a backflow of blood from the heart to the lungs causing major complications due to the blood pooling in the lungs. If left untreated, PDAs are known to cause severe infections and impairs normal function of the lungs.After a series of referrals from different NICU centres across UP, Nishu was brought to the Max Hospital on the 17th day after his birth. Besides severe respiratory distress and congestive heart failure, he also had partially treated sepsis with meningitis.After initial stabilisation, the baby was given optimal respiratory support and appropriate antibiotics. The doctors planned for a device closure of PDA for which his parents were counselled."Post closure, the baby could finally take oral feed by day three of the procedure. Subsequent care was completed over the next few days and in follow-up consultations, the child has been doing increasingly well," Ramalingam Kalyan, Director and HoD, Paediatrics, Max Super Speciality Hospital, Vaishali, said in a statement.The Piccolo device is already being used the world over to treat PDA in pre-term and new-born babies since it is approved by the US FDA. In India, this has only been used as a life-saving measure in south India, but now with the advent of this technology in north India, there is hope for such babies to lead a better, healthier life, with quicker healing."PDA cases were until now being treated with medicine-based management, waiting for the child to grow up and gain weight and reach the age of three to six months so that they could go ahead with surgical intervention. However, this could also be fatal since, as the child grew, the lungs would open to their maximum capacity and also soften up causing the blood flow to the lungs to increase more leading to major complications," said Neeraj Awasthy, Principal Consultant & Incharge, Paediatric Cardiology, Max Super Speciality Hospital, Saket."With the use of Piccolo, it is now possible to treat even a pre-term who weighs as low as 700 grams. The device is inserted through the leg vein and the procedure takes just a few minutes. While the preparation of this procedure at our end is longer, the good news is that the recovery starts soon after," Awasthy added.--IANSrvt/arm